BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3911059)

  • 1. Glycosylation of lipoproteins: chemistry and biological implications.
    Flückiger R
    Monogr Atheroscler; 1985; 13():53-62. PubMed ID: 3911059
    [No Abstract]   [Full Text] [Related]  

  • 2. [Separation of lipoproteins as a function of their apolipoprotein composition. Clinical applications].
    Fruchart JC
    Ann Biol Clin (Paris); 1986; 44(2):116-21. PubMed ID: 3092704
    [No Abstract]   [Full Text] [Related]  

  • 3. Distribution of tocopherol and apolipoprotein A-I immunoreactivity in rat liver chromatin.
    Panin LE; Polyakov LM; Kolosova NG; Russkikh GS; Poteryaeva ON
    Membr Cell Biol; 1998; 11(5):631-40. PubMed ID: 9672881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vivo metabolism of VLDL-apolipoprotein-B, -CIII and -E in normolipidemic subjects.
    Dinkel RE; Barrett PH; Demant T; Parhofer KG
    Nutr Metab Cardiovasc Dis; 2006 Apr; 16(3):215-21. PubMed ID: 16580589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Structure and metabolism of lipoproteins].
    Beucler I; Salmon S; Petit E; Ayrault-Jarrier M; Polonovski J
    Ann Biol Clin (Paris); 1986; 44(5):531-5. PubMed ID: 3544976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular basis of atherosclerosis: concepts derived from studies of lipoprotein metabolism and cell biology.
    Mahley RW
    Clin Invest Med; 1986 Nov; 9(4):304-8. PubMed ID: 3026707
    [No Abstract]   [Full Text] [Related]  

  • 7. [Human apolipoprotein E: polymorphism and binding domain of the receptors].
    Bekaert ED; Ayrault-Jarrier M; Polonovski J
    Biochimie; 1986 May; 68(5):629-37. PubMed ID: 3015256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The important role of apolipoprotein C-III in lipoprotein metabolism].
    Fruchart JC; Duriez P
    C R Seances Soc Biol Fil; 1995; 189(5):889-97. PubMed ID: 8673634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interaction between genes and diet as a determinant of the plasma levels of cholesterol].
    López Miranda J; Ordovás JM; Pérez Jiménez F
    Med Clin (Barc); 1998 Oct; 111(14):546-51. PubMed ID: 9859082
    [No Abstract]   [Full Text] [Related]  

  • 11. [Apoproteins in dyslipoproteinemia (author's transl)].
    Dewailly P
    Diabete Metab; 1981 Mar; 7(1):51-61. PubMed ID: 6786929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defects of lipoprotein metabolism in familial combined hyperlipidaemia.
    de Graaf J; Stalenhoef AF
    Curr Opin Lipidol; 1998 Jun; 9(3):189-96. PubMed ID: 9645500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein B and lipoprotein metabolism.
    Sparks JD; Sparks CE
    Adv Lipid Res; 1985; 21():1-46. PubMed ID: 3895843
    [No Abstract]   [Full Text] [Related]  

  • 14. Inherited disorders of lipid transport.
    Schonfeld G
    Endocrinol Metab Clin North Am; 1990 Jun; 19(2):229-57. PubMed ID: 2192872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein function in health and disease: insights from natural mutations.
    Franceschini G
    Eur J Clin Invest; 1996 Sep; 26(9):733-46. PubMed ID: 8889435
    [No Abstract]   [Full Text] [Related]  

  • 16. Type III hyperlipoproteinemia: recent insights into the genetic defect of familial dysbetalipoproteinemia.
    Mahley RW; Angelin B
    Adv Intern Med; 1984; 29():385-411. PubMed ID: 6369930
    [No Abstract]   [Full Text] [Related]  

  • 17. The composition, structural properties and binding of very-low-density and low-density lipoproteins to the LDL receptor in normo- and hypertriglyceridemia: relation to the apolipoprotein E phenotype.
    Dergunov AD; Novoselov AV; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biol Chem; 2005 May; 386(5):441-52. PubMed ID: 15927888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Structure and metabolism of plasma lipoproteins].
    Polonovski J; Beucler I
    Pathol Biol (Paris); 1983 Apr; 31(4):225-34. PubMed ID: 6346237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Structure, metabolism, functions and plasma changes in high density lipoproteins (HDL)].
    Dewailly P; Sezille G; Jaillard J
    Journ Annu Diabetol Hotel Dieu; 1980 May; ():65-81. PubMed ID: 6995678
    [No Abstract]   [Full Text] [Related]  

  • 20. ApoC-III bound to apoB-containing lipoproteins increase with insulin resistance in Cherokee Indian youth.
    Blackett PR; Blevins KS; Quintana E; Stoddart M; Wang W; Alaupovic P; Lee ET
    Metabolism; 2005 Feb; 54(2):180-7. PubMed ID: 15690311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.